Literature DB >> 34520792

Down-regulation of lncRNA MEG3 promotes chronic low dose cadmium exposure-induced cell transformation and cancer stem cell-like property.

Hsuan-Pei Lin1, Matthew Rea2, Zhishan Wang3, Chengfeng Yang4.   

Abstract

Cadmium (Cd) is a toxic heavy metal and one of carcinogens that cause lung cancer. However, the exact mechanism of Cd carcinogenesis remains unclear. To investigate the mechanism of Cd carcinogenesis, we exposed human bronchial epithelial cells (BEAS-2B) to a low dose of Cd (2.5 μM, CdCl2) for 9 months, which caused cell malignant transformation and generated cancer stem cell (CSC)-like cells. The goal of this study is to investigate the underlying mechanism. The long non-coding RNA (lncRNA) microarray analysis showed that the expression level of a tumor suppressive lncRNA maternally expressed 3 (MEG3) is significantly down-regulated in Cd-transformed cells, which is confirmed by further q-PCR analysis. Mechanistically, it was found that chronic Cd exposure up-regulates the levels of DNA methyltransferases (DNMTs), which increases the methylation of the differentially methylated region (DMR) 1.5 kb upstream of MEG3 transcription start site to reduce MEG3 expression. Functional studies showed that stably overexpressing MEG3 in Cd-transformed cells significantly reduces their transformed phenotypes. Moreover, stably overexpressing MEG3 in parental non-transformed human bronchial epithelial cells significantly impaired the capability of chronic Cd exposure to induce cell transformation and CSC-like property. Further mechanistic studies revealed that the cell cycle inhibitor p21 level is reduced and retinoblastoma protein (Rb) phosphorylation is increased in Cd-transformed cells to promote cell cycle progression. In addition, Cd-transformed cells also expressed higher levels of Bcl-xL and displayed apoptosis resistance. In contrast, stably overexpressing MEG3 increased p21 levels and reduced Rb phosphorylation and Bcl-xL levels in Cd-exposed cells and reduced their cell cycle progression and apoptosis resistance. Together, these findings suggest that MEG3 down-regulation may play important roles in Cd-induced cell transformation and CSC-like property by promoting cell cycle progression and apoptosis resistance.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cadmium; Carcinogenesis; Epigenetics; Long Non-coding RNA; MEG3

Mesh:

Substances:

Year:  2021        PMID: 34520792      PMCID: PMC8511074          DOI: 10.1016/j.taap.2021.115724

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  54 in total

1.  Epigenetic effect of cadmium on global de novo DNA hypomethylation in the cadmium-induced ventral body wall defect (VBWD) in the chick model.

Authors:  Takashi Doi; Prem Puri; Amanda McCann; John Bannigan; Jennifer Thompson
Journal:  Toxicol Sci       Date:  2011-01-27       Impact factor: 4.849

2.  Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein.

Authors:  M R Campanero; E K Flemington
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

3.  E2F1 interacts with BCL-xL and regulates its subcellular localization dynamics to trigger cell death.

Authors:  Céline Vuillier; Steven Lohard; Aurélie Fétiveau; Jennifer Allègre; Cémile Kayaci; Louise E King; Frédérique Braun; Sophie Barillé-Nion; Fabien Gautier; Laurence Dubrez; Andrew P Gilmore; Philippe P Juin; Laurent Maillet
Journal:  EMBO Rep       Date:  2017-12-12       Impact factor: 8.807

4.  Analysis of aberrant methylation in DNA repair genes during malignant transformation of human bronchial epithelial cells induced by cadmium.

Authors:  Zhi-heng Zhou; Yi-xiong Lei; Cai-xia Wang
Journal:  Toxicol Sci       Date:  2011-11-23       Impact factor: 4.849

5.  Essential role for Rac in heregulin beta1 mitogenic signaling: a mechanism that involves epidermal growth factor receptor and is independent of ErbB4.

Authors:  Chengfeng Yang; Ying Liu; Mark A Lemmon; Marcelo G Kazanietz
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

6.  BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells.

Authors:  Eleni D Lagadinou; Alexander Sach; Kevin Callahan; Randall M Rossi; Sarah J Neering; Mohammad Minhajuddin; John M Ashton; Shanshan Pei; Valerie Grose; Kristen M O'Dwyer; Jane L Liesveld; Paul S Brookes; Michael W Becker; Craig T Jordan
Journal:  Cell Stem Cell       Date:  2013-01-17       Impact factor: 24.633

Review 7.  Human respiratory disease: environmental carcinogens and lung cancer risk.

Authors:  J C Kleinjans; J M van Maanen; F J van Schooten
Journal:  Ciba Found Symp       Date:  1993

Review 8.  Lung cancer stem cells, p53 mutations and MDM2.

Authors:  Venkat Sundar Gadepalli; Swati Palit Deb; Sumitra Deb; Raj R Rao
Journal:  Subcell Biochem       Date:  2014

9.  Expression and correlation of Bcl-2 with pathological grades in human glioma stem cells.

Authors:  Bo Qiu; Yong Wang; Jun Tao; Yunjie Wang
Journal:  Oncol Rep       Date:  2012-05-04       Impact factor: 3.906

10.  Expression of ncRNAs on the DLK1-DIO3 Locus Is Associated With Basal and Mesenchymal Phenotype in Breast Epithelial Progenitor Cells.

Authors:  Zuzana Budkova; Anna Karen Sigurdardottir; Eirikur Briem; Jon Thor Bergthorsson; Snævar Sigurdsson; Magnus Karl Magnusson; Gunnhildur Asta Traustadottir; Thorarinn Gudjonsson; Bylgja Hilmarsdottir
Journal:  Front Cell Dev Biol       Date:  2020-06-16
View more
  1 in total

1.  Identification of Candidate lncRNA and Pseudogene Biomarkers Associated with Carbon-Nanotube-Induced Malignant Transformation of Lung Cells and Prediction of Potential Preventive Drugs.

Authors:  Guangtao Chang; Dongli Xie; Jianchen Hu; Tong Wu; Kangli Cao; Xiaogang Luo
Journal:  Int J Environ Res Public Health       Date:  2022-03-02       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.